{
  "trial_id": "NCT00532441",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Histological or cytological proof of hepatocellular or biliary tract carcinomas",
      "label": "met",
      "evidence": "not amenable to curative resection or transplantation"
    },
    {
      "criterion": "Prior cancer treatment completed at least 30 days prior to being registered for protocol therapy and recovered from the acute toxicity effects of the regimen.",
      "label": "met",
      "evidence": "completed treatment"
    },
    {
      "criterion": "Patients may have had radiofrequency ablation, cryosurgery or embolization, but must have documented progressive disease with the involved lesion, or at least one previously untreated lesion.",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Peripheral neuropathy \u2264 grade 1.",
      "label": "met",
      "evidence": "\u2264 grade 1"
    },
    {
      "criterion": "Patients must agree to abstain from frozen or fresh grapefruit or grapefruit juice for 5 days prior to, and during treatment.",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Written informed consent and HIPAA authorization for release of personal health information.",
      "label": "met",
      "evidence": "written informed consent"
    },
    {
      "criterion": "Age \u2265 18 years at time of consent.",
      "label": "met",
      "evidence": "\u2265 18 years"
    }
  ],
  "exclusion": [
    {
      "criterion": "No previous treatment with EGFR inhibitors.",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "No symptomatic brain metastasis. A subject with prior brain metastasis may be considered if they have completed their treatment for brain metastasis, no longer require corticosteroids, and are asymptomatic.",
      "label": "not_met",
      "evidence": "no symptomatic brain metastasis"
    },
    {
      "criterion": "No Child-Pugh B or C liver cirrhosis.",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "No active corneal erosions or history of abnormal corneal sensitivity test.",
      "label": "not_met",
      "evidence": "no active corneal erosions"
    },
    {
      "criterion": "No history of aneurysm or arteriovenous malformation.",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "No hemorrhage/bleeding event > CTCAE Grade 3 within 30 days prior to begin registered for protocol therapy.",
      "label": "not_met",
      "evidence": "no hemorrhage/bleeding event"
    },
    {
      "criterion": "No clinically significant infections as judged by the treating investigator.",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "No condition that impairs patient's ability to swallow whole pills.",
      "label": "not_met",
      "evidence": "no condition impairing swallowing"
    }
  ],
  "notes": "The patient is a 55 year old man with lower urinary tract symptoms. He has no previous treatment with EGFR inhibitors and no symptomatic brain metastasis.",
  "_meta": {
    "topic_id": "24",
    "trial_id": "NCT00532441",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}